Session

Eosinophilic esophagitis and GORD

DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE
DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE

PSYCHOLOGICAL SYMPTOMS, NOT REFLUX PARAMETERS, ARE ASSOCIATED WITH GASTROESOPHAGEAL REFLUX DISEASE SYMPTOM REPORTING
PSYCHOLOGICAL SYMPTOMS, NOT REFLUX PARAMETERS, ARE ASSOCIATED WITH GASTROESOPHAGEAL REFLUX DISEASE SYMPTOM REPORTING

EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

COMPARED TO HEALTHY SUBJECTS, OESOPHAGEAL MUCOSA FROM PATIENTS WITH GASTRO-OESOPHAGEAL REFLUX DISEASE HAVE INCREASED NERVE GROWTH FACTOR-RELEASING MAST CELLS, AND FEWER DENDRITIC CELLS
COMPARED TO HEALTHY SUBJECTS, OESOPHAGEAL MUCOSA FROM PATIENTS WITH GASTRO-OESOPHAGEAL REFLUX DISEASE HAVE INCREASED NERVE GROWTH FACTOR-RELEASING MAST CELLS, AND FEWER DENDRITIC CELLS

COMPARED TO HEALTHY SUBJECTS, OESOPHAGEAL MUCOSA FROM PATIENTS WITH GASTRO-OESOPHAGEAL REFLUX DISEASE HAVE INCREASED NERVE GROWTH FACTOR-RELEASING MAST CELLS, AND FEWER DENDRITIC CELLS
COMPARED TO HEALTHY SUBJECTS, OESOPHAGEAL MUCOSA FROM PATIENTS WITH GASTRO-OESOPHAGEAL REFLUX DISEASE HAVE INCREASED NERVE GROWTH FACTOR-RELEASING MAST CELLS, AND FEWER DENDRITIC CELLS

Eosinophilic esophagitis and GORD  et al.

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Eosinophilic esophagitis and GORD  et al.

EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Eosinophilic esophagitis and GORD  et al.

PSYCHOLOGICAL SYMPTOMS, NOT REFLUX PARAMETERS, ARE ASSOCIATED WITH GASTROESOPHAGEAL REFLUX DISEASE SYMPTOM REPORTING
PSYCHOLOGICAL SYMPTOMS, NOT REFLUX PARAMETERS, ARE ASSOCIATED WITH GASTROESOPHAGEAL REFLUX DISEASE SYMPTOM REPORTING

Eosinophilic esophagitis and GORD  et al.

DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE
DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE

Eosinophilic esophagitis and GORD  et al.

Item 1 - 10 / 10
1